CJC-1295 (Mod GRF 1-29) & Hexarelin Blend (10mg)

What is in this blend?

This vial combines two research peptides that act on different receptors involved in growth hormone release, with 10mg of peptide in total.

• CJC-1295 without DAC (Mod GRF 1-29): GHRH(1-29) with four amino-acid substitutions, which acts on the GHRH receptor.
• Hexarelin (examorelin): a synthetic hexapeptide that acts on the ghrelin (GHS) receptor.

Regulatory status

Neither peptide is an approved medicine. GHRH analogues and growth hormone-releasing peptides are prohibited at all times in competitive sport by the World Anti-Doping Agency. This product is sold for laboratory research use only.

Related products

• Each peptide on its own: CJC-1295 without DAC and Hexarelin.
• Other Mod GRF 1-29 combinations: with GHRP-2, with GHRP-6 and with ipamorelin.

Handling and research-use notice

Store and handle this material as stated on the label and certificate of analysis for your batch; see our guide to storing research peptides. This product is sold for laboratory research use only. It is not a medicine or supplement and is not for human or veterinary use.